ProSight: a Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population

NANot yet recruitingINTERVENTIONAL

Enrollment

2,527

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Lung CancerColorectal CancerLiver CancerGrastic CancerEsophageal Cancer

Interventions

DEVICE

multi-cancer early detection

Blood collection for multi-cancer early detection（MCED）, followed by clinical diagnosis based on the results of MCED and standard-of-care screening

All Listed Sponsors

collaborator

Fudan University

OTHER

lead

Shanghai Weihe Medical Laboratory Co., Ltd.

INDUSTRY